Q1 2018

Latest Quarterly Results
Ended September 30, 2017

$724,936

Research and development YTD

$785,668

Net cash used in operations YTD

Stock Snapshot

Propanc Biopharma, Inc. OTCQB: PPCB
Change/Percentage
Day Range
52 Week Range
Volume
Detailed Quote Stock Charts Historical Quote